Biotricity Preferred Shareholders Convert 97% of Preferred A Shares into Restricted Common Stock

REDWOOD CITY, CA - Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company, announced that 97% of its Preferred A shares have been converted into Restricted Common Stock. This move reflects increased confidence and commitment from existing shareholders.

Dr. Waqaas Al-Siddiq, Founder and CEO, noted that this conversion signifies strong enthusiasm for the company's future milestones. Recent achievements include securing three GPO partnerships covering 87% of US hospitals, increased margins, and revenues, alongside reduced losses. Biotricity is progressing towards being EBITDA neutral and cash-flow positive.

These accomplishments, combined with a growing market opportunity, have bolstered shareholder confidence.